<p>CLINICAL TRIALS AND DILEMMAS: History and definition of delayed cerebral ischemia. - Clinical, transcranial Doppler ultrasound, radiological features and prognostic significance of delayed cerebral ischemia. - Identifying patient report outcomes relevant to aneurysmal subarachnoid hemorrhage follow-up. - Global cerebral atrophy after subarachnoid hemorrhage: A possible marker of acute brain injury and assessment of its impact on outcome. - Protein biomarkers in patients with subarachnoid hemorrhage, vasospasm and delayed ischemic neurological deficits. - Randomized trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). - Angiographic vasospasm versus cerebral infarction as outcome measures after aneurysmal subarachnoid hemorrhage. - Development of Nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: From laboratory to clinical trial. - Magnesium sulphate for aneurysmal subarachnoid hemorrhage: Why, how, and current controversy. - Prolonged intravenous infusion of sodium nitrite delivers nitric oxide (NO) in healthy volunteers. – Special article: Proposed mechanism of cerebral vasospasm: Our hypothesis and current topics. - NEUROCRITICAL CARE: Monitoring of cerebral hemodynamics and oxygenation to detect delayed ischemic neurological deficit after aneurysmal subarachnoid hemorrhage: - Usefulness of three dimensional computed tomography to quantify the subarachnoid hemorrhage volume: Prediction of symptomatic vasospasm. - COSBID-M3: A platform for multimodal monitoring, data collection and research in neurocritical care. -Transcranial Doppler as a routine in the treatment of vasospasm following subarachnoid hemorrhage. – Systemic interleukin-6 levels reflect illness course and prognosis of patients with spontaneous nonanueyrsmal subarachnoid hemorrhage. - Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following subarachnoid hemorrhage. - SURGICAL AND ENDOVASCULAR MANAGEMENT: Removal of clots in subarachnoid space could reduce the vasospasm after subarachnoid hemorrhage. – Effect of lumbar puncture in patients with neurismal subarachnoid hemorrhage treated microsurgically or endovascularly. – Effect of aneurysm treatment modalities on cerebral vasospasm after neurismal subarachnoid hemorrhage. – Endovascular management of post-hemorrhagic cerebral vasospasm: Indications, technical nuances and results. – The concept of a hybrid operation room: Applications in cerebrovascular surgery. – Computerized occlusion rating of embolized ruptured intracranial aneurysms: Relation to intra- and postinterventional aneurysm rehemorrhage. - SPREADING DEPOLARIZATIONS: Spreading ischemia after aneurismal subarachnoid hemorrhage. – Full-band electrocorticography of spreading depolarizations in patients with neurismal subarachnoid hemorrhage. – Cerebral glucose and spreading depolarization in patients with neurismal subarachnoid hemorrhage. – Evaluation of intracranial electrocorticography recording strips and tissue partial pressure of oxygen and temperature probes for radiofrequency induced heating. – Criteria for the diagnosis of non-infectious and infectious complications after neurismal subarachnoid hemorrhage. – Neurovascular coupling during spreading depolarizations. - NEUROVASCULAR COUPLING AND MICROVASCULATURE: Subarachnoid blood converts neurally evoked vasodilation to vasoconstriction in rat brain cortex. - Impact of subarachnoid hemorrhage on parenchymal arteriolar function. - SAH-induced suppression of voltage-gated K<sup>+ </sup>(K<sub>v</sub>) channel currents in parenchymal arteriolar myocytes involves activation of the HB-EGF/EGFR pathway. -<br>Mechanisms of microthrombosis and microcirculatory constriction after experimental subarachnoid hemorrhage. - Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. -Cerebral microvasculature is an early target of subarachnoid hemorrhage. -PRECLINICAL STUDIES: The roles of early brain injury in cerebral vasospasm following subarachnoid hemorrhage: From clinical and scientific aspects. -Matricellular protein: A new player in cerebral vasospasm following subarachnoid hemorrhage. - Role of platelet-derived growth factor in cerebral vasospasm after subarachnoid hemorrhage in rats. - Relevance of animal models of subarachnoid hemorrhage for examining neurobehavioral changes. - Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: A review . - Attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage by the bronchodilator KMUP-3. - Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: Systematic review. - Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates delayed deterioration associated with vasospasm in subarachnoid hemorrhage. - Statin induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage. - Role of bilirubin oxidation products in the pathophysiology of DIND following SAH. - RISK FACTORS: Association of morphologic and demographic features of intracranial aneurysms with their rupture: A retrospective analysis. - Location, interaction and anticipation of aneurysm formation. - Symptomatic vasospasm in elderly patients with aneurysmal subarachnoid hemorrhage: Comparison with non-elderly patients</p>